First National Daily eMedical Newspaper of India
Nobody Reports News Better Than Us  
Editorial (Dr K K Aggarwal)                                                                                       (Dr RN Tandon)
We have improved our eMediNexus Platform with a far superior user experience.
Please click here to try it
25th December, 2017
Straight from the Heart: IMA ICMR Initiatives - Annual Round Up

IMA endorses National Guidelines for Stem Cell Research (NGSCR): The NGSCR-2013 covers only stem cell research, both basic and translational, and not therapy as the same is experimental as on date. Any stem cell use in patients, other than that for hematopoietic stem cell reconstitution for approved indications, is investigational and must only be done within the purview of an approved and monitored clinical trial. Every use of stem cells in patients outside an approved clinical trial is malpractice.

Points about stem cell therapy every IMA member must know

  • There are no approved indications for stem cell therapy other than the hematopoietic stem cell transplantation (HSCT) for haematological disorders. Stem cell therapies other than HSCT are investigational and can be conducted only in the form of a clinical trial following ICMR guidelines for clinical research after obtaining necessary regulatory approvals. Use of stem cells for any other purpose outside the domain of clinical trial is unethical (Clause 10.3.1).... read more
Top News

CAG slams FSSAI over lapses in enforcing food safety

The Comptroller and Auditor General of India (CAG) has slammed the Union Health Ministry and its body Food Safety and Standards Authority of India (FSSAI) for not framing regulations governing various procedures, guidelines and mechanisms in line with the provisions of the Food Safety and Standards Act, 2006.... read more

Medical tourism value in India to touch USD 9 bn by 2020

The government has stated that the value of medical tourism in India is likely to reach a value of USD 9 billion by 2020 as compared to the USD 3 billon in 2015. Tourism Minister KJ ALphons informed the Lok Sabha that India has emerged as a major medical tourism destination over the years.... read more

Practice Updates
Three in Ten Doses of Metformin Missed by Patients with Type 2 Diabetes

Patients with type 2 diabetes are least likely to adhere to the most commonly prescribed medication for their disease, potentially because of its adverse-event profile, suggests new research published online in Diabetes, Obesity and more

High Mortality Rate in ESRD Patients After LVAD Placement

Renal failure is a leading predictor of poor prognosis after cardiac surgery. In a cohort of Medicare beneficiaries, only about 48.4% of patients with end-stage renal disease (ESRD) survived to discharge after LVAD placement, more

High-definition Colonoscopy Sufficient for IBD Surveillance

High-definition colonoscopy is as effective as more advanced techniques, including dye spraying chromoendoscopy (DCE) and virtual chromoendoscopy (VCE), for detecting colonic neoplastic lesions during inflammatory bowel disease (IBD) surveillance, suggest the results from a noninferiority trial published in the American Journal of more

Guidance for Opioid Use After Inpatient General Surgery

A new guideline from Dartmouth University surgeons, published online in the Journal of the American College of Surgeons, suggests that for inpatients having general surgery, receiving opioids the day before hospital discharge best predicts postdischarge more

Low Folate, Vitamin D Linked with First-Episode Psychosis

Nutritional deficiencies, especially in folate and vitamin D, are linked with first-episode psychosis (FEP), suggests new research published online in Schizophrenia Bulletin. Researchers noted significantly lower levels of folate and vitamin D in patients with FEP, compared to healthy more

eMedi Humor
Medicolegal Corner
eMedi Quiz
a. Mitsuda's reaction
b. Medina-Ramirez reaction
c. Fischer's test
d. Fernandez reaction
Lifestyle Updates
Inspirational Story 1: : It‘s All Good
Inspirational Story 2: A simple gesture
IMA policy is to prescribe quality drugs at affordable cost
Bioequivalence studies are an important aspect of making medicine affordable
New Delhi, 24 December 2017: In what can be called a long overdue move, the Ministry of Health and Family Welfare amended the law to make bioequivalence studies compulsory for certain classes of generic drugs manufactured in India this year. The Drugs & Cosmetics Rules, 2017 was formally amended through a notification on April 3 to incorporate the change. The new law required bioequivalence studies to be performed on drugs with low solubility.
Bioequivalence studies are studies conducted to establish that two medicines, normally the original patented drug and a generic version, have the same biological equivalence – that is, that they work the same way, to the same extent and for the same purpose.
To Read More or Comment, Click Here